Company Profile

AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE2089.4533.7 (+1.64 % )
PREV CLOSE (Rs.) 2055.75
OPEN PRICE (Rs.) 2051.20
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 476
TODAY'S LOW / HIGH (Rs.)2035.30 2093.10
52 WK LOW / HIGH (Rs.)1529 2420
NSE2087.75 28.9 (+1.4 % )
PREV CLOSE(Rs.) 2058.85
OPEN PRICE (Rs.) 2058.80
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 2087.75 (7 )
VOLUME 75581
TODAY'S LOW / HIGH(Rs.) 2031.30 2095.00
52 WK LOW / HIGH (Rs.)1531.95 2435

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 9.83492
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 24.85
ROCE (%) 34.00
Incorporation Year : 1979

Management Info :

Mannalal B Agrawal - Chairman Yogesh M Agrawal - Managing Director

Registered Office :

Address : Ajanta House,Charkop ,Kandivali (W),
Mumbai,
Maharashtra-400067

Phone : 91-22-66061000

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS More
29Nov11-29-2021$Ajanta Pharma submits disclosures Ajanta Pharma submits disclo

Ajanta Pharma has informed that the Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 29, 2021 for Aayush M Agrawal, Trustee Aayush Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma has informed that the Exchange has received Discl..
08Nov11-08-2021$Ajanta Pharma informs about transcript of earnings call Ajanta Pharma informs about

Further to its communication dated 29th October 2021 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Ajanta Pharma has informed that the written transcript of the earnings call held on 29th October 2021 at 4.45 pm has been uploaded on the Company’s website and can be accessed through the link http://www.ajantapharma.com/AdminData/Results/EarningsCallTranscriptQ2(JulSep)2021-22.pdf.

The above information is a part of company’s filings submitted to BSE.

Further to its communication dated 29th October 2021 on earning..
22Oct10-22-2021$Ajanta Pharma informs about board meeting Ajanta Pharma informs about

Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Friday, 29th October 2021 to: Approve and take on record unaudited consolidated & standalone Financial Results of the Company for the second quarter and half year ended 30th September 2021, Consider declaration of interim dividend, if any, for the financial year ending 31st March 2022 and Fixation of Wednesday, 10th November 2021 as the Record Date for the payment of interim dividend, if declared.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 29 of the Listing Regulations, Ajanta Ph..
21Oct10-21-2021$ Board Meeting Intimation for Board Meeting Intimation For Quarterly Results And Consider Declaration Of Interim Dividend Board Meeting Intimation fo
AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Listing Regulations, we hereby inform that a Meeting of the Board of Directors of the Company will be held on Friday, 29th October 2021 to inter-alia: 1. Approve and take on record unaudited consolidated & standalone Financial Results of the Company for the second quarter and half year ended 30th September 2021 and 2. Consider declaration of interim dividend, if any, for the financial year ending 31st March 2022. 3. Fixation of Wednesday, 10th November 2021 as the Record Date for the payment of interim dividend, if declared. You are requested to please take a note of the same and disseminate to all concerned.
AJANTA PHARMA LTD.has informed BSE that the meeting of the Boar..
21Oct10-21-2021$Ajanta Pharma informs about board meeting Ajanta Pharma informs about

Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Friday, 29th October 2021 to approve and take on record unaudited consolidated & standalone Financial Results of the Company for the second quarter and half year ended 30th September 2021, consider declaration of interim dividend, if any, for the financial year ending 31st March 2022, and fixation of Wednesday, 10th November 2021 as the Record Date for the payment of interim dividend, if declared.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 29 of the Listing Regulations, Ajanta Ph..
Financials More
Rs. in Millions
QTR Sep 21 ANNUAL 21
Net Profit1968.56756.4
Gross Profit 2547.9 9020.9
Operating Profit 2852.610204.8
Net Sales 8237.127185.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Torrent Pharma (BSE)
 3075.05 (4.73%)
M.Cap ( in Cr)
52032.53
Abbott India (BSE)
 18733.05 (0.38%)
M.Cap ( in Cr)
39806.42
Piramal Enterprises (BSE)
 2581.15 (2.47%)
M.Cap ( in Cr)
61602.66
Kwality Pharma (BSE)
 998.25 (5.00%)
M.Cap ( in Cr)
1035.80
Natural Capsules (BSE)
 239.25 (17.51%)
M.Cap ( in Cr)
186.40
Shareholding Pattern More
NON-INSTITUTION 8.43 %
PROMOTERS 70.34 %
MUTUAL FUNDS/UTI 10.26 %
FI/BANKS/INSURANCE 1.25 %
GOVERNMENT 0.43 %
FII 0 %
F & O Quotes